Komori
Share Issuance and Disposal4586Medrx Co.,Ltd.Pharmaceuticals

Notice Regarding the Large-Scale Exercise of the 35th Stock Acquisition Rights (with Exercise Price Adjustment Clause) Issued Through a Third-Party Allotment

From 1 July to 7 July 2026, 16,921 of the 35th Stock Acquisition Rights were exercised, and 1,692,100 new shares were delivered. As a result, the number of unexercised stock acquisition rights decreased from 138,760 to 121,839.

Worth reading
69In focus
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
1692100
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Large-scale exercise of the 35th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)

Who receives how much

1,692,100 new shares (from 1 July to 7 July 2026)

グロース・キャピタル株式会社 (the allottee at the time of issuance on 5 June 2026)

The lower thin line represents the existing number of shares to which these shares will be added.

Terms of the stock acquisition rights
Exercise price
¥46 (1 July–3 July), ¥49 (6 July and 7 July). Details of the adjustment clause and floor price: Not disclosed
Number of Stock Acquisition Rights
Total issued: 147,820; unexercised as of the end of the previous month: 138,760; currently unexercised: 121,839
Most recent equity financing
Timing 5 June 2026 / Type Issuance of the 35th Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed
Details of issuance or disposal
ItemDetails
Type of issuance or disposalLarge-scale exercise of the 35th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)
Number of shares to be issued or disposed of1,692,100 new shares (from 1 July to 7 July 2026)
Intended allotteeグロース・キャピタル株式会社 (the allottee at the time of issuance on 5 June 2026)
Total number of issued shares60,271,100 shares (including 2 treasury shares) → Not disclosed
Exercise price¥46 (1 July–3 July), ¥49 (6 July and 7 July). Details of the adjustment clause and floor price: Not disclosed
Number of Stock Acquisition RightsTotal issued: 147,820; unexercised as of the end of the previous month: 138,760; currently unexercised: 121,839
Most recent equity financingTiming 5 June 2026 / Type Issuance of the 35th Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Due to the large-scale exercise of the 35th Stock Acquisition Rights.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Large-Scale Exercise of the 35th Stock Acquisition Rights (with Exercise Price Adjustment Clause) Issued Through a Third-Party Allotment | Medrx Co.,Ltd. (4586) timely disclosure | Komori